186 related articles for article (PubMed ID: 34365540)
21. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery.
Ngamruengphong S; Wolfsen HC; Wallace MB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1424-1429.e2; quiz e81. PubMed ID: 23735443
[TBL] [Abstract][Full Text] [Related]
22. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of esophageal cancer after distal gastrectomy: a prospective study.
Li HH; Zhang QZ; Xu L; Hu JW
Int J Surg; 2008 Apr; 6(2):129-35. PubMed ID: 18442806
[TBL] [Abstract][Full Text] [Related]
24. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
25. A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
van der Werf LR; Wijnhoven BPL; Fransen LFC; van Sandick JW; Nieuwenhuijzen GAP; Busweiler LAD; van Hillegersberg R; Wouters MWJM; Luyer MDP; van Berge Henegouwen MI
Ann Surg; 2019 Nov; 270(5):868-876. PubMed ID: 31634182
[TBL] [Abstract][Full Text] [Related]
26. Surgery of gastric cancer and esophageal cancer: Does age matter?
Nienhueser H; Kunzmann R; Sisic L; Blank S; Strowitzk MJ; Bruckner T; Jäger D; Weichert W; Ulrich A; Büchler MW; Ott K; Schmidt T
J Surg Oncol; 2015 Sep; 112(4):387-95. PubMed ID: 26303645
[TBL] [Abstract][Full Text] [Related]
27. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
Tsai C; Mueller A; Maubach J; Warschkow R; Nussbaum DP; Schmied BM; Blazer D; Gloor B; Worni M
Dig Surg; 2020; 37(3):249-257. PubMed ID: 31340206
[TBL] [Abstract][Full Text] [Related]
28. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
29. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin.
DiMusto PD; Orringer MB
Ann Thorac Surg; 2007 Jun; 83(6):1993-8; discussion 1998-9. PubMed ID: 17532385
[TBL] [Abstract][Full Text] [Related]
30. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
31. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
32. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X; Liang H; Li Z; Xue Y; Wang Y; Zhou Z; Yu J; Bu Z; Chen L; Du Y; Wang X; Wu A; Li G; Su X; Xiao G; Cui M; Wu D; Chen L; Wu X; Zhou Y; Zhang L; Dang C; He Y; Zhang Z; Sun Y; Li Y; Chen H; Bai Y; Qi C; Yu P; Zhu G; Suo J; Jia B; Li L; Huang C; Li F; Ye Y; Xu H; Wang X; Yuan Y; E JY; Ying X; Yao C; Shen L; Ji J;
Lancet Oncol; 2021 Aug; 22(8):1081-1092. PubMed ID: 34252374
[TBL] [Abstract][Full Text] [Related]
33. Gastric tube cancer after esophagectomy for cancer: a systematic review.
Gentile D; Riva P; Da Roit A; Basato S; Marano S; Castoro C
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 31111880
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
35. [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].
Hölscher AH; Bollschweiler E; Beckurts KT; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():169-72. PubMed ID: 9101821
[TBL] [Abstract][Full Text] [Related]
36. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study.
Dijksterhuis WPM; Kalff MC; Wagner AD; Verhoeven RHA; Lemmens VEPP; van Oijen MGH; Gisbertz SS; van Berge Henegouwen MI; van Laarhoven HWM
J Natl Cancer Inst; 2021 Nov; 113(11):1551-1560. PubMed ID: 33837791
[TBL] [Abstract][Full Text] [Related]
37. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
[TBL] [Abstract][Full Text] [Related]
38. Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma.
Song Y; Tao G; Guo Q; Yang X; Zhu H; Wang W; Sun X
Oncotarget; 2016 Apr; 7(16):21347-52. PubMed ID: 26870996
[TBL] [Abstract][Full Text] [Related]
39. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.
Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Murphy MAB; Maru DM; Weston B; Lee JH; Rogers JE; Trail A; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Das P; Hofstetter WL; Badgwell BD; Ajani JA
Gastric Cancer; 2020 Sep; 23(5):904-912. PubMed ID: 32347396
[TBL] [Abstract][Full Text] [Related]
40. Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study.
Pape M; Vissers PAJ; Dijksterhuis WPM; Bertwistle D; McDonald L; Mostert B; Derks S; Oving IM; Verhoeven RHA; van Laarhoven HWM
Ther Adv Med Oncol; 2023; 15():17588359231162576. PubMed ID: 36970109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
